Clustered cases of Bordetella pertussis infection cause high levels of IgG antibodies against pertussis toxin in adolescents in Gaobeidian city, China

Epidemiology and Infection

Volumn 142, Issue 4, 2014, Pages 738-743

  Wu, Y ^a,b   Zhu, B ^a,b   Gao, Y ^a,b   Shi, Z ^c   Wang, J ^c   Wang, H ^c   Shao, Z ^a,b  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases ^*  (China)

^c Gaobeidian Center for Disease Control and Prevention   (China)

Author keywords

Bordetella pertussis

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; PERTUSSIS TOXIN; BACTERIUM ANTIBODY; DIPHTHERIA PERTUSSIS TETANUS VACCINE; IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CHILD; CHINA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HIGH SCHOOL; HUMAN; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; PERTUSSIS; SEROPREVALENCE; AGE DISTRIBUTION; CLUSTER ANALYSIS; IMMUNOGLOBULIN BLOOD LEVEL; INCIDENCE; INFECTION RISK; INFECTION SENSITIVITY; PRESCHOOL CHILD; SCHOOL CHILD; SEROLOGY; BLOOD; BORDETELLA PERTUSSIS; EPIDEMIC; IMMUNOLOGY; RISK;

ADOLESCENT; ANTIBODIES, BACTERIAL; BORDETELLA PERTUSSIS; CHILD; CHILD, PRESCHOOL; CHINA; CROSS-SECTIONAL STUDIES; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; DISEASE OUTBREAKS; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; ODDS RATIO; PERTUSSIS TOXIN; WHOOPING COUGH;

EID: 84901703375     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268813003099     Document Type: Article

References (24)

1. Zepp F, et al. Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infectious Diseases 2011; 11: 557-570.
2. Pan American Health Organization. Final report of the XIX Technical Advisory Group (TAG) Meeting on Vaccine-preventable Diseases of the Pan American Health Organization, Buenos Aires, Argentina, July 2011 (http://new.paho.org/ hq/index.php?option=com- content&view=article&id=1862&Itemid=1674).
3. Cherry J. Epidemic pertussis in 2012 - the resurgence of a vaccine-preventable disease. New England Journal of Medicine 2012; 367: 785-787.
4. Skowronski DM, et al. The changing age and seasonal profile of pertussis in Canada. Journal of Infection 2002; 185: 1696.
5. Torres J, et al. Outbreak of whooping cough with a high attack rate in well-vaccinated children and adolescents. Enfermedades Infecciosas y Microbiología Clínica 2011; 29: 564-567.
6. Melker HE, et al. Re-emergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data. Emerging Infectious Diseases 2000; 6: 348-357.
7. Mink C, et al. Outbreak of pertussis in a fully immunized adolescent and adult population. Clinical Infectious Diseases 1992; 14: 464-471.
8. World Health Organization. Pertussis surveillance, a global meeting, Geneva, 16-18 October 2000 (2001). Departments of Vaccines and Biologicals. Geneva: World Health Organization, WHO/V&B/01.19.
9. Mossong J, et al. Seroepidemiology of diphtheria and pertussis in Luxembourg I 2000. Epidemiology and Infection 2006; 134: 573-578.
10. Yih W, et al. The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989-1998. Journal of Infectious Diseases 2000; 182: 1409-16.
11. Greenberg DP. Pertussis in adolescents: increasing incidence brings attention to the need for booster immunization of adolescents. Pediatric Infectious Disease 2005; 24: 721-728.
12. World Health Organization. Immunization profile - China
13. Qi Z, et al. The seroepidemiology of immunoglobulin G antibodies against pertussis toxin in China: a cross sectional study. BMC Infectious Diseases 2012; 12: 138.
14. Ou J, et al. History and progress on the research of pertussis in china review. Journal of Clinical Pediatrics 2007; 25: 607-609.
15. Fu J, et al. Analysis on pertussis epidemiology in Zhejiang province in 1954-2004. Chinese Journal of Vaccines and Immunization 2005; 11: 279-281.
16. Yan Y, et al. Analysis on epidemiology in 1963-2002 and control strategy on pertussis in Henan province. Chinese Journal of Vaccines and Immunization 2005; 11: 402-404.
17. Muller F, et al. Laboratory diagnosis of pertussis: state of the art in 1997. Journal of Clinical Microbiology 1997; 35: 2435-2443.
18. Versteegh F, et al. Age-specific long-term course of IgG antibodies to pertussis toxin after symptomatic infection with Boerderella pertussis. Epidemiology and Infection 2005; 133: 737-748.
19. Hallander HO, et al. Kinetics and sensitivity of ELISA IgG pertussis antitoxin after infection and vaccination with bordetella pertussis in young children. APMIS 2009; 117: 797-807.
20. Horby P, et al. A boarding school outbreak of pertussis in adolescents: value of laboratory diagnostic methods. Epidemiology and Infection 2005; 133: 229-236.
21. Duranoglu L, et al. Evaluation of pertussis immunity status in schoolchildren immunized with whole-cell vaccine. Epidemiology and Infection 2010; 138: 299-303.
22. Melker H, et al. Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with bordetella pertussis. Journal of Clinical Microbiology 2000; 38: 800-806.
23. Hallander H, et al. Seroprevalence of pertussis antitoxin (anti-PT) in Sweden before and 10 years after the introduction of a universal childhood pertussis vaccination program. APMIS 2009; 117: 912-9
24. Cherry JD, et al. Defining pertussis epidemiology, clinical, microbiologic and serologic perspectives. Pediatric Infectious Disease Journal 2005; 24: s25-s34.